Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Merck KGaA (GB:0O14)
LSE:0O14
Holding GB:0O14?
Track your performance easily
0O14 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€134.35 - €176.85
Previous Close€142.02
Volume13.92K
Average Volume (3M)107.25K
Market Cap
€62.15B
Enterprise Value€70.99B
Total Cash (Recent Filing)€1.64B
Total Debt (Recent Filing)€10.40B
Price to Earnings (P/E)23.5
Beta0.82
Next Earnings
Mar 06, 2025EPS Estimate
€2.24Last Dividend Ex-Date
Apr 29, 2024Dividend Yield1.55%
Share Statistics
EPS (TTM)6.04
Shares OutstandingN/A
10 Day Avg. Volume139,964
30 Day Avg. Volume107,255
Standard Deviation0.08
R-Squared0.10
Alpha0.00796
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)3.15
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€182.45Price Target Upside28.47% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Merck KGaA News
PremiumPre-Earnings
Is 0O14 a Buy, Before Earnings?
PremiumPre-Earnings
Merck KGaA (0O14) Q4 Earnings Cheat Sheet
PremiumGlobal Markets
Do Not Miss These DAX 40 Stocks’ Earnings
PremiumPre-Earnings
Is 0O14 a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Growth ExpectationsA return to growth in Life Sciences and Process Solutions for the first time in five quarters is expected to give additional confidence to investors on future growth expectations.
Market TrendsElectronics recovery is playing out due to AI, improving the profile of the division.
ValuationAnalyst re-iterates BUY as MRK is attractively valued compared to its end markets and peers.
Bears Say
Earnings QualityThere is a negative perception surrounding Healthcare-driven EBITDA beats due to cost releases, which investors might see as lower quality compared to topline-driven growth.
Growth ChallengesCore topics indicate slower growth in Healthcare due to fading tailwinds and challenges in Life Sciences.
Sales GuidanceThe guidance indicates that the upper end of the sales range is out of reach, aligning with previous messaging but possibly disappointing investors hoping for higher sales figures.
---
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
13.44% Mutual Funds
<0.01% Other Institutional Investors
73.61% Public Companies and
Individual Investors
0O14 FAQ
What was Merck KGaA’s price range in the past 12 months?
Merck KGaA lowest share price was €134.35 and its highest was €176.85 in the past 12 months.
What is Merck KGaA’s market cap?
Currently, no data Available
When is Merck KGaA’s upcoming earnings report date?
Merck KGaA’s upcoming earnings report date is Mar 06, 2025 which is in 100 days.
How were Merck KGaA’s earnings last quarter?
Merck KGaA released its earnings results on Nov 14, 2024. The company reported €2.3 earnings per share for the quarter, beating the consensus estimate of €2.266 by €0.034.
Is Merck KGaA overvalued?
According to Wall Street analysts Merck KGaA’s price is currently Undervalued.
Does Merck KGaA pay dividends?
Merck KGaA pays a Annually dividend of €2.2 which represents an annual dividend yield of 1.55%. See more information on Merck KGaA dividends here
What is Merck KGaA’s EPS estimate?
Merck KGaA’s EPS estimate is €2.24.
How many shares outstanding does Merck KGaA have?
Merck KGaA has 129,242,250 shares outstanding.
What happened to Merck KGaA’s price movement after its last earnings report?
Merck KGaA reported an EPS of €2.3 in its last earnings report, beating expectations of €2.266. Following the earnings report the stock price went down -2.007%.
Which hedge fund is a major shareholder of Merck KGaA?
Currently, no hedge funds are holding shares in GB:0O14
---
Merck KGaA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.47%
12-Months-Change
Fundamentals
Return on Equity
9.50%
Trailing 12-Months
Asset Growth
2.24%
Trailing 12-Months
Company Description
Merck KGaA
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. In its performance materials segment, the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
---
0O14 Stock 12 Month Forecast
Average Price Target
€182.45
▲(28.47% Upside)
Technical Analysis
Best Analysts Covering 0O14
1 Year
1 Year Success Rate
19/27 ratings generated profit
1 Year Average Return
+14.34%
reiterated a buy rating 4 months ago
Copying Peter Spengler's trades and holding each position for 1 Year would result in 70.37% of your transactions generating a profit, with an average return of +14.34% per trade.
---